Not Signed In - Bradley Pharmaceuticals Announces FDA Approval Of Elestrin(TM) (estradiol Gel 0.06%)
Wed, 20 Dec 2006 08:00 AM EST
... Bradley Pharmaceuticals, Inc. (NYSE: BDY) announced today that the Company has been notified by BioSante Pharmaceuticals (Amex: BPA) that they received approval from the Food and Drug Administration to market Elestrin(TM) (formerly called Bio-E-Gel(R)), BioSante's estradiol transdermal gel indicated for the treatment of moderate to severe hot flashes in menopausal women. [click link for full article] ...
Related Topics
- Estradiol
- Fluoride Gel
- Electrophoresis
- Sodium Fluoride Dental Gel
- Testosterone Gel
- Coal Tar Shampoo
- Estradiol Topical Gel
- Vaccine Testing & Approval
- Estradiol and Levonorgestrel
- Adapalene Topical
- Tazarotene Skin Gel
- Benzoyl Peroxide and Clindamycin Skin Gel
- Podofilox Gel
- Estradiol Injection
- Estradiol and Norgestimate
- Cyanocobalamin Nasal Gel
- Tacrolimus ointment
- Estradiol Vaginal Tablets
- Tretinoin
- Mammography
email this page
print this page
bookmark this page
feedback on this page
